T1	Participants 51 82	acute myeloid leukemia patients
T2	Participants 343 419	chronic myeloid leukemia, multiple myeloma, and acute myeloid leukemia (AML)
T3	Participants 547 575	newly diagnosed AML patients
T4	Participants 607 695	German AML Cooperative Group and the Dutch-Belgian Hematology Oncology Cooperative group
T5	Participants 1603 1606	AML
